Alliance Clinical Research

Oceanside, California 92056

0 studies enrolling now · 13 studies all time

What they study most

Chronic Idiopathic Constipation, Crohn Disease, Crohn's Disease, Eosinophilic Esophagitis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Ulcerative Colitis

Studies at this site

• Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
• Efficacy and Safety Study of Ozanimod in Ulcerative Colitis — Completed
• A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis — Completed
• A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease — Completed
• The Safety And Efficacy Of Maintenance Therapy With CP-690,550 — Completed
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis — Completed
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation — Completed